nodes	percent_of_prediction	percent_of_DWPC	metapath
Risedronate—PTGS2—ovarian follicle—polycystic ovary syndrome	0.0897	0.254	CbGeAlD
Risedronate—Gastrointestinal tract irritation—Metformin—polycystic ovary syndrome	0.0396	0.0935	CcSEcCtD
Risedronate—Abdominal bloating—Metformin—polycystic ovary syndrome	0.0297	0.0702	CcSEcCtD
Risedronate—FDPS—adrenal cortex—polycystic ovary syndrome	0.0259	0.0733	CbGeAlD
Risedronate—PTGS2—Nicotinate metabolism—NMNAT3—polycystic ovary syndrome	0.0254	0.114	CbGpPWpGaD
Risedronate—FDPS—endometrium—polycystic ovary syndrome	0.0232	0.0655	CbGeAlD
Risedronate—FDPS—uterus—polycystic ovary syndrome	0.0213	0.0603	CbGeAlD
Risedronate—FDPS—pituitary gland—polycystic ovary syndrome	0.021	0.0593	CbGeAlD
Risedronate—FDPS—adipose tissue—polycystic ovary syndrome	0.0209	0.059	CbGeAlD
Risedronate—FDPS—adrenal gland—polycystic ovary syndrome	0.0187	0.0529	CbGeAlD
Risedronate—FDPS—female gonad—polycystic ovary syndrome	0.0175	0.0494	CbGeAlD
Risedronate—FDPS—vagina—polycystic ovary syndrome	0.0173	0.0491	CbGeAlD
Risedronate—FDPS—endocrine gland—polycystic ovary syndrome	0.0162	0.0459	CbGeAlD
Risedronate—Contusion—Metformin—polycystic ovary syndrome	0.0162	0.0383	CcSEcCtD
Risedronate—Accidental injury—Metformin—polycystic ovary syndrome	0.016	0.0378	CcSEcCtD
Risedronate—PTGS2—Nicotinamide salvaging—NAMPT—polycystic ovary syndrome	0.0159	0.071	CbGpPWpGaD
Risedronate—PTGS2—embryo—polycystic ovary syndrome	0.0121	0.0343	CbGeAlD
Risedronate—Injury—Metformin—polycystic ovary syndrome	0.0112	0.0264	CcSEcCtD
Risedronate—Pain in extremity—Metformin—polycystic ovary syndrome	0.0103	0.0242	CcSEcCtD
Risedronate—PTGS2—adrenal cortex—polycystic ovary syndrome	0.00994	0.0281	CbGeAlD
Risedronate—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00947	0.0224	CcSEcCtD
Risedronate—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00937	0.0221	CcSEcCtD
Risedronate—Breast disorder—Metformin—polycystic ovary syndrome	0.00927	0.0219	CcSEcCtD
Risedronate—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00917	0.0217	CcSEcCtD
Risedronate—FDPS—SREBP signalling—RBP4—polycystic ovary syndrome	0.00905	0.0405	CbGpPWpGaD
Risedronate—Abdominal distension—Metformin—polycystic ovary syndrome	0.00892	0.0211	CcSEcCtD
Risedronate—PTGS2—endometrium—polycystic ovary syndrome	0.00888	0.0251	CbGeAlD
Risedronate—Influenza—Metformin—polycystic ovary syndrome	0.00887	0.021	CcSEcCtD
Risedronate—Angina pectoris—Metformin—polycystic ovary syndrome	0.00864	0.0204	CcSEcCtD
Risedronate—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.0085	0.0201	CcSEcCtD
Risedronate—PTGS2—Nicotinate metabolism—NAMPT—polycystic ovary syndrome	0.00844	0.0378	CbGpPWpGaD
Risedronate—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00824	0.0195	CcSEcCtD
Risedronate—PTGS2—uterus—polycystic ovary syndrome	0.00818	0.0231	CbGeAlD
Risedronate—PTGS2—pituitary gland—polycystic ovary syndrome	0.00803	0.0227	CbGeAlD
Risedronate—PTGS2—adipose tissue—polycystic ovary syndrome	0.008	0.0226	CbGeAlD
Risedronate—Infestation NOS—Metformin—polycystic ovary syndrome	0.0079	0.0187	CcSEcCtD
Risedronate—Infestation—Metformin—polycystic ovary syndrome	0.0079	0.0187	CcSEcCtD
Risedronate—PTGS2—Prostaglandin Synthesis and Regulation—PTGER3—polycystic ovary syndrome	0.00761	0.0341	CbGpPWpGaD
Risedronate—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00748	0.0177	CcSEcCtD
Risedronate—PTGS2—adrenal gland—polycystic ovary syndrome	0.00717	0.0203	CbGeAlD
Risedronate—Rhinitis—Metformin—polycystic ovary syndrome	0.00711	0.0168	CcSEcCtD
Risedronate—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00699	0.0165	CcSEcCtD
Risedronate—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00697	0.0165	CcSEcCtD
Risedronate—PTGS2—female gonad—polycystic ovary syndrome	0.00669	0.0189	CbGeAlD
Risedronate—PTGS2—vagina—polycystic ovary syndrome	0.00665	0.0188	CbGeAlD
Risedronate—Eye disorder—Metformin—polycystic ovary syndrome	0.00663	0.0157	CcSEcCtD
Risedronate—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00659	0.0156	CcSEcCtD
Risedronate—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—AKR1C3—polycystic ovary syndrome	0.00649	0.0291	CbGpPWpGaD
Risedronate—Angiopathy—Metformin—polycystic ovary syndrome	0.00644	0.0152	CcSEcCtD
Risedronate—Immune system disorder—Metformin—polycystic ovary syndrome	0.00641	0.0152	CcSEcCtD
Risedronate—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.0064	0.0151	CcSEcCtD
Risedronate—PTGS2—endocrine gland—polycystic ovary syndrome	0.00622	0.0176	CbGeAlD
Risedronate—Malnutrition—Metformin—polycystic ovary syndrome	0.00618	0.0146	CcSEcCtD
Risedronate—Flatulence—Metformin—polycystic ovary syndrome	0.00609	0.0144	CcSEcCtD
Risedronate—Muscle spasms—Metformin—polycystic ovary syndrome	0.00594	0.014	CcSEcCtD
Risedronate—Syncope—Metformin—polycystic ovary syndrome	0.00554	0.0131	CcSEcCtD
Risedronate—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00543	0.0128	CcSEcCtD
Risedronate—Hypertension—Metformin—polycystic ovary syndrome	0.00533	0.0126	CcSEcCtD
Risedronate—Myalgia—Metformin—polycystic ovary syndrome	0.00526	0.0124	CcSEcCtD
Risedronate—Chest pain—Metformin—polycystic ovary syndrome	0.00526	0.0124	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00522	0.0123	CcSEcCtD
Risedronate—Infection—Metformin—polycystic ovary syndrome	0.00501	0.0118	CcSEcCtD
Risedronate—Shock—Metformin—polycystic ovary syndrome	0.00496	0.0117	CcSEcCtD
Risedronate—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00494	0.0117	CcSEcCtD
Risedronate—Skin disorder—Metformin—polycystic ovary syndrome	0.0049	0.0116	CcSEcCtD
Risedronate—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—NMNAT3—polycystic ovary syndrome	0.00486	0.0218	CbGpPWpGaD
Risedronate—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00459	0.0109	CcSEcCtD
Risedronate—Paraesthesia—Metformin—polycystic ovary syndrome	0.00453	0.0107	CcSEcCtD
Risedronate—Dyspnoea—Metformin—polycystic ovary syndrome	0.00449	0.0106	CcSEcCtD
Risedronate—Dyspepsia—Metformin—polycystic ovary syndrome	0.00444	0.0105	CcSEcCtD
Risedronate—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00435	0.0103	CcSEcCtD
Risedronate—Fatigue—Metformin—polycystic ovary syndrome	0.00435	0.0103	CcSEcCtD
Risedronate—Constipation—Metformin—polycystic ovary syndrome	0.00431	0.0102	CcSEcCtD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00413	0.0185	CbGpPWpGaD
Risedronate—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00412	0.00975	CcSEcCtD
Risedronate—Urticaria—Metformin—polycystic ovary syndrome	0.004	0.00947	CcSEcCtD
Risedronate—Abdominal pain—Metformin—polycystic ovary syndrome	0.00399	0.00942	CcSEcCtD
Risedronate—PTGS2—C-MYB transcription factor network—PTCRA—polycystic ovary syndrome	0.00379	0.017	CbGpPWpGaD
Risedronate—PTGS2—Prostaglandin Synthesis and Regulation—CYP11A1—polycystic ovary syndrome	0.00374	0.0167	CbGpPWpGaD
Risedronate—Asthenia—Metformin—polycystic ovary syndrome	0.00362	0.00855	CcSEcCtD
Risedronate—FDPS—SREBP signalling—PPARG—polycystic ovary syndrome	0.00359	0.0161	CbGpPWpGaD
Risedronate—Pruritus—Metformin—polycystic ovary syndrome	0.00357	0.00843	CcSEcCtD
Risedronate—FDPS—SREBP signalling—INS—polycystic ovary syndrome	0.00352	0.0158	CbGpPWpGaD
Risedronate—Diarrhoea—Metformin—polycystic ovary syndrome	0.00345	0.00815	CcSEcCtD
Risedronate—Dizziness—Metformin—polycystic ovary syndrome	0.00333	0.00788	CcSEcCtD
Risedronate—PTGS2—Overview of nanoparticle effects—BAX—polycystic ovary syndrome	0.00328	0.0147	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00327	0.0146	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00327	0.0146	CbGpPWpGaD
Risedronate—Vomiting—Metformin—polycystic ovary syndrome	0.00321	0.00758	CcSEcCtD
Risedronate—Rash—Metformin—polycystic ovary syndrome	0.00318	0.00751	CcSEcCtD
Risedronate—Dermatitis—Metformin—polycystic ovary syndrome	0.00318	0.00751	CcSEcCtD
Risedronate—Headache—Metformin—polycystic ovary syndrome	0.00316	0.00747	CcSEcCtD
Risedronate—Nausea—Metformin—polycystic ovary syndrome	0.00299	0.00708	CcSEcCtD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—polycystic ovary syndrome	0.0029	0.013	CbGpPWpGaD
Risedronate—PTGS2—Overview of nanoparticle effects—CRP—polycystic ovary syndrome	0.00283	0.0127	CbGpPWpGaD
Risedronate—PTGS2—Prostaglandin Synthesis and Regulation—PRL—polycystic ovary syndrome	0.00279	0.0125	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.00274	0.0123	CbGpPWpGaD
Risedronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—ATF1—polycystic ovary syndrome	0.0027	0.0121	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.0026	0.0116	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00248	0.0111	CbGpPWpGaD
Risedronate—PTGS2—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.00235	0.0105	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.00211	0.00943	CbGpPWpGaD
Risedronate—FDPS—Metabolism—NMNAT3—polycystic ovary syndrome	0.00201	0.00901	CbGpPWpGaD
Risedronate—PTGS2—Overview of nanoparticle effects—BCL2—polycystic ovary syndrome	0.002	0.00895	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.00192	0.0086	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.00188	0.0084	CbGpPWpGaD
Risedronate—FDPS—Metabolism—LPCAT2—polycystic ovary syndrome	0.00184	0.00824	CbGpPWpGaD
Risedronate—FDPS—Metabolism—SUOX—polycystic ovary syndrome	0.00184	0.00824	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.00182	0.00814	CbGpPWpGaD
Risedronate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—polycystic ovary syndrome	0.00172	0.00769	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ISYNA1—polycystic ovary syndrome	0.00171	0.00766	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.00167	0.00749	CbGpPWpGaD
Risedronate—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—NAMPT—polycystic ovary syndrome	0.00161	0.00723	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—polycystic ovary syndrome	0.00157	0.00705	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—INSR—polycystic ovary syndrome	0.00157	0.00703	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.00156	0.00699	CbGpPWpGaD
Risedronate—PTGS2—S1P1 pathway—VEGFA—polycystic ovary syndrome	0.0015	0.0067	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.00148	0.00663	CbGpPWpGaD
Risedronate—PTGS2—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.00147	0.00659	CbGpPWpGaD
Risedronate—FDPS—Metabolism—AKR1C2—polycystic ovary syndrome	0.00146	0.00652	CbGpPWpGaD
Risedronate—FDPS—Metabolism—TEAD2—polycystic ovary syndrome	0.00146	0.00652	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.0014	0.00627	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.00138	0.00617	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—CCNB1—polycystic ovary syndrome	0.00136	0.00608	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—PLAT—polycystic ovary syndrome	0.00135	0.00605	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—TAB1—polycystic ovary syndrome	0.00124	0.00553	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PNPLA2—polycystic ovary syndrome	0.00122	0.00546	CbGpPWpGaD
Risedronate—FDPS—Metabolism—SRD5A1—polycystic ovary syndrome	0.00116	0.00518	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.00113	0.00505	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—polycystic ovary syndrome	0.00111	0.00498	CbGpPWpGaD
Risedronate—FDPS—Metabolism—STAR—polycystic ovary syndrome	0.0011	0.00494	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.00109	0.00488	CbGpPWpGaD
Risedronate—PTGS2—Overview of nanoparticle effects—IL6—polycystic ovary syndrome	0.00103	0.00463	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—NCOR1—polycystic ovary syndrome	0.00103	0.00459	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00099	0.00443	CbGpPWpGaD
Risedronate—FDPS—Metabolism—HMMR—polycystic ovary syndrome	0.000983	0.0044	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—NGFR—polycystic ovary syndrome	0.000941	0.00421	CbGpPWpGaD
Risedronate—FDPS—Metabolism—HSD3B1—polycystic ovary syndrome	0.000938	0.0042	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000927	0.00415	CbGpPWpGaD
Risedronate—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—polycystic ovary syndrome	0.000882	0.00395	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000879	0.00393	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—MTHFR—polycystic ovary syndrome	0.000874	0.00391	CbGpPWpGaD
Risedronate—FDPS—Metabolism—LHB—polycystic ovary syndrome	0.000855	0.00383	CbGpPWpGaD
Risedronate—FDPS—Metabolism—HSD3B2—polycystic ovary syndrome	0.000836	0.00374	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—CRP—polycystic ovary syndrome	0.000831	0.00372	CbGpPWpGaD
Risedronate—FDPS—Metabolism—AKR1C1—polycystic ovary syndrome	0.00081	0.00362	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000783	0.0035	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000783	0.0035	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.000782	0.0035	CbGpPWpGaD
Risedronate—FDPS—Metabolism—SULT2A1—polycystic ovary syndrome	0.000745	0.00334	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.000738	0.0033	CbGpPWpGaD
Risedronate—FDPS—Metabolism—RRM2—polycystic ovary syndrome	0.000722	0.00323	CbGpPWpGaD
Risedronate—FDPS—Metabolism—YAP1—polycystic ovary syndrome	0.000696	0.00311	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—INS—polycystic ovary syndrome	0.000695	0.00311	CbGpPWpGaD
Risedronate—FDPS—Metabolism—NAMPT—polycystic ovary syndrome	0.000668	0.00299	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000664	0.00297	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CYP11A1—polycystic ovary syndrome	0.00066	0.00295	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000656	0.00294	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000655	0.00293	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—LEP—polycystic ovary syndrome	0.000643	0.00288	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	0.000638	0.00286	CbGpPWpGaD
Risedronate—FDPS—Metabolism—AKR1C3—polycystic ovary syndrome	0.000623	0.00279	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000622	0.00278	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CYP17A1—polycystic ovary syndrome	0.000614	0.00275	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—BCL2—polycystic ovary syndrome	0.000609	0.00273	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000608	0.00272	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000593	0.00266	CbGpPWpGaD
Risedronate—PTGS2—Disease—NMNAT3—polycystic ovary syndrome	0.000576	0.00258	CbGpPWpGaD
Risedronate—FDPS—Metabolism—TH—polycystic ovary syndrome	0.000531	0.00238	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000518	0.00232	CbGpPWpGaD
Risedronate—FDPS—Metabolism—SLC2A4—polycystic ovary syndrome	0.000516	0.00231	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000504	0.00226	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CYP19A1—polycystic ovary syndrome	0.000486	0.00217	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000482	0.00216	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.00046	0.00206	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.00045	0.00201	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000441	0.00197	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SUOX—polycystic ovary syndrome	0.000441	0.00197	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000435	0.00195	CbGpPWpGaD
Risedronate—FDPS—Metabolism—GNAS—polycystic ovary syndrome	0.000433	0.00194	CbGpPWpGaD
Risedronate—FDPS—Metabolism—NCOR1—polycystic ovary syndrome	0.000413	0.00185	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ISYNA1—polycystic ovary syndrome	0.00041	0.00184	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000401	0.00179	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CYP1A1—polycystic ovary syndrome	0.000391	0.00175	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000374	0.00167	CbGpPWpGaD
Risedronate—FDPS—Metabolism—MTHFR—polycystic ovary syndrome	0.000365	0.00163	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000362	0.00162	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000355	0.00159	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—TEAD2—polycystic ovary syndrome	0.000349	0.00156	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000349	0.00156	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000335	0.0015	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.00033	0.00148	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000316	0.00141	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000304	0.00136	CbGpPWpGaD
Risedronate—PTGS2—Disease—RPL37A—polycystic ovary syndrome	0.000297	0.00133	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PPARG—polycystic ovary syndrome	0.000296	0.00132	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000292	0.00131	CbGpPWpGaD
Risedronate—FDPS—Metabolism—POMC—polycystic ovary syndrome	0.000292	0.00131	CbGpPWpGaD
Risedronate—FDPS—Metabolism—INS—polycystic ovary syndrome	0.00029	0.0013	CbGpPWpGaD
Risedronate—PTGS2—Disease—HMMR—polycystic ovary syndrome	0.000281	0.00126	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000277	0.00124	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—STAR—polycystic ovary syndrome	0.000264	0.00118	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000261	0.00117	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—IL6—polycystic ovary syndrome	0.00024	0.00107	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000236	0.00106	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HMMR—polycystic ovary syndrome	0.000235	0.00105	CbGpPWpGaD
Risedronate—PTGS2—Disease—AKR1C1—polycystic ovary syndrome	0.000232	0.00104	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000225	0.00101	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000222	0.000994	CbGpPWpGaD
Risedronate—PTGS2—Disease—FGF18—polycystic ovary syndrome	0.000215	0.000962	CbGpPWpGaD
Risedronate—PTGS2—Disease—RBP4—polycystic ovary syndrome	0.000213	0.000954	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.00021	0.000942	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—LHB—polycystic ovary syndrome	0.000205	0.000917	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HSD3B2—polycystic ovary syndrome	0.0002	0.000896	CbGpPWpGaD
Risedronate—PTGS2—Disease—GAB1—polycystic ovary syndrome	0.000196	0.000878	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000194	0.000868	CbGpPWpGaD
Risedronate—PTGS2—Disease—NAMPT—polycystic ovary syndrome	0.000191	0.000856	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000178	0.000799	CbGpPWpGaD
Risedronate—PTGS2—Disease—AKR1C3—polycystic ovary syndrome	0.000178	0.000798	CbGpPWpGaD
Risedronate—PTGS2—Disease—TNRC6B—polycystic ovary syndrome	0.000175	0.000786	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—RRM2—polycystic ovary syndrome	0.000173	0.000774	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—YAP1—polycystic ovary syndrome	0.000167	0.000746	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NAMPT—polycystic ovary syndrome	0.00016	0.000717	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000159	0.000712	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000158	0.000708	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000157	0.000703	CbGpPWpGaD
Risedronate—PTGS2—Disease—TCF7L2—polycystic ovary syndrome	0.00015	0.000673	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—AKR1C3—polycystic ovary syndrome	0.000149	0.000668	CbGpPWpGaD
Risedronate—PTGS2—Disease—SLC2A4—polycystic ovary syndrome	0.000148	0.000661	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000147	0.000658	CbGpPWpGaD
Risedronate—PTGS2—Disease—PRL—polycystic ovary syndrome	0.000141	0.000631	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—TH—polycystic ovary syndrome	0.000127	0.000569	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SLC2A4—polycystic ovary syndrome	0.000124	0.000554	CbGpPWpGaD
Risedronate—PTGS2—Disease—NCOR1—polycystic ovary syndrome	0.000118	0.000529	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CYP19A1—polycystic ovary syndrome	0.000116	0.000521	CbGpPWpGaD
Risedronate—PTGS2—Disease—NRG1—polycystic ovary syndrome	0.000116	0.000519	CbGpPWpGaD
Risedronate—PTGS2—Disease—MTHFR—polycystic ovary syndrome	0.000104	0.000467	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GNAS—polycystic ovary syndrome	0.000104	0.000465	CbGpPWpGaD
Risedronate—PTGS2—Disease—IRS2—polycystic ovary syndrome	9.93e-05	0.000444	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NCOR1—polycystic ovary syndrome	9.89e-05	0.000443	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CYP1A1—polycystic ovary syndrome	9.37e-05	0.00042	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—MTHFR—polycystic ovary syndrome	8.74e-05	0.000391	CbGpPWpGaD
Risedronate—PTGS2—Disease—IRS1—polycystic ovary syndrome	8.67e-05	0.000388	CbGpPWpGaD
Risedronate—PTGS2—Disease—INS—polycystic ovary syndrome	8.3e-05	0.000372	CbGpPWpGaD
Risedronate—PTGS2—Disease—AKT2—polycystic ovary syndrome	8.02e-05	0.000359	CbGpPWpGaD
Risedronate—PTGS2—Disease—SERPINE1—polycystic ovary syndrome	7.62e-05	0.000341	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PPARG—polycystic ovary syndrome	7.09e-05	0.000317	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—POMC—polycystic ovary syndrome	6.99e-05	0.000313	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—INS—polycystic ovary syndrome	6.95e-05	0.000311	CbGpPWpGaD
Risedronate—PTGS2—Disease—IL6—polycystic ovary syndrome	3.63e-05	0.000162	CbGpPWpGaD
